231 related articles for article (PubMed ID: 18669715)
1. Maternal biochemical serum screening for Down syndrome in pregnancy with human immunodeficiency virus infection.
Le Meaux JP; Tsatsaris V; Schmitz T; Fulla Y; Launay O; Goffinet F; Azria E
Obstet Gynecol; 2008 Aug; 112(2 Pt 1):223-30. PubMed ID: 18669715
[TBL] [Abstract][Full Text] [Related]
2. Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
Brossard P; Boulvain M; Coll O; Barlow P; Aebi-Popp K; Bischof P; Martinez de Tejada B; ;
AIDS; 2008 Oct; 22(15):2013-7. PubMed ID: 18784463
[TBL] [Abstract][Full Text] [Related]
3. The impact of protease inhibitors on maternal serum screening analyte levels in pregnant women who are HIV positive.
Einstein FH; Wright RL; Trentacoste S; Gross S; Merkatz IR; Bernstein PS
Am J Obstet Gynecol; 2004 Sep; 191(3):1004-8. PubMed ID: 15467580
[TBL] [Abstract][Full Text] [Related]
4. Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women.
Sritippayawan S; Vachirasrisoontra C
J Med Assoc Thai; 2005 Apr; 88(4):449-54. PubMed ID: 16146246
[TBL] [Abstract][Full Text] [Related]
5. Combined first-trimester Down syndrome screening in HIV-infected women.
Chougrani I; Muller F; Marcelin L; Tsatsaris V; Abric J; Luton D; Guibourdenche J; Azria E
Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():274-8. PubMed ID: 27391901
[TBL] [Abstract][Full Text] [Related]
6. Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance.
Rudnicka AR; Wald NJ; Huttly W; Hackshaw AK
Prenat Diagn; 2002 Oct; 22(10):893-7. PubMed ID: 12378572
[TBL] [Abstract][Full Text] [Related]
7. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
Rice JD; McIntosh SF; Halstead AC
Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
[TBL] [Abstract][Full Text] [Related]
8. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
[TBL] [Abstract][Full Text] [Related]
9. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
10. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A
Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324
[TBL] [Abstract][Full Text] [Related]
11. Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus.
Huttly W; Rudnicka A; Wald NJ
Prenat Diagn; 2004 Oct; 24(10):804-7. PubMed ID: 15503275
[TBL] [Abstract][Full Text] [Related]
12. Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers.
Wald NJ; Morris JK; Ibison J; Wu T; George LM
Prenat Diagn; 2006 Jun; 26(6):559-64. PubMed ID: 16700087
[TBL] [Abstract][Full Text] [Related]
13. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A
Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094
[TBL] [Abstract][Full Text] [Related]
14. The relationship between maternal serum alpha-fetoprotein and maternal haemoglobin.
Bartha JL; Omar KM; Soothill PW
Prenat Diagn; 2004 Aug; 24(8):609-12. PubMed ID: 15305347
[TBL] [Abstract][Full Text] [Related]
15. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
Lamlertkittikul S; Chandeying V
J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
[TBL] [Abstract][Full Text] [Related]
16. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province].
Hu YL;
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809
[TBL] [Abstract][Full Text] [Related]
17. Cell-free fetal DNA levels in pregnancies conceived by IVF.
Pan PD; Peter I; Lambert-Messerlian GM; Canick JA; Bianchi DW; Johnson KL
Hum Reprod; 2005 Nov; 20(11):3152-6. PubMed ID: 16006472
[TBL] [Abstract][Full Text] [Related]
18. Prenatal screening for Down syndrome: the problem of recurrent false-positives.
Wald NJ; Huttly WJ; Rudnicka AR
Prenat Diagn; 2004 May; 24(5):389-92. PubMed ID: 15164416
[TBL] [Abstract][Full Text] [Related]
19. Second trimester prenatal screening for Down syndrome: the associations between the levels of serum markers in successive pregnancies.
Huang T; Boucher K; Summers AM
Prenat Diagn; 2007 Dec; 27(12):1138-42. PubMed ID: 17960787
[TBL] [Abstract][Full Text] [Related]
20. Down syndrome maternal serum marker screening after 18 weeks of gestation: a countrywide study.
Dreux S; Nguyen C; Czerkiewicz I; Schmitz T; Azria E; Fouré MA; Muller F;
Am J Obstet Gynecol; 2013 May; 208(5):397.e1-5. PubMed ID: 23353023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
